Gene Biotherapeutics, Inc. Operating Cash Flow
Gene Biotherapeutics, Inc. reported Operating Cash Flow of -$1.13 million for the 12-month period ending 2020-12-31, per its 10-K/A filed 2022-04-14.
Discontinued › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2022-04-14
- Gene Biotherapeutics, Inc. net cash provided by (used in) operating activities for the quarter ending 2020-12-31 was -$337.87K.
- Gene Biotherapeutics, Inc. net cash provided by (used in) operating activities for the quarter ending 2020-09-30 was -$479.80K.
- Gene Biotherapeutics, Inc. net cash provided by (used in) operating activities for the quarter ending 2020-06-30 was -$221.48K.
- Gene Biotherapeutics, Inc. net cash provided by (used in) operating activities for the quarter ending 2020-03-31 was -$93.86K.
- Gene Biotherapeutics, Inc. net cash provided by (used in) operating activities for fiscal 2020 was -$1.13M.
- Gene Biotherapeutics, Inc. net cash provided by (used in) operating activities for fiscal 2019 was -$137.16K.
- Gene Biotherapeutics, Inc. net cash provided by (used in) operating activities for fiscal 2018 was -$451.50K.
- Gene Biotherapeutics, Inc. net cash provided by (used in) operating activities for fiscal 2017 was -$1.06M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month | Net Cash Provided by (Used in) Operating Activities 12 month as first filed | Net Cash Provided by (Used in) Operating Activities 90 month | Net Cash Provided by (Used in) Operating Activities 93 month | Net Cash Provided by (Used in) Operating Activities 120 month | Net Cash Provided by (Used in) Operating Activities 123 month |
|---|---|---|---|---|---|---|---|---|---|
| 2020-12-31 | -$337.87K derived: 10-K/A 12 month − 10-Q 9 month · filed 2022-04-14 | -$817.66K derived: sum of 2 quarters · filed 2022-04-14 | -$1.04M derived: sum of 3 quarters · filed 2022-04-14 | -$1.13M 10-K/A · filed 2022-04-14 | |||||
| 2020-09-30 | -$479.80K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-27 | -$701.28K derived: sum of 2 quarters · filed 2021-10-27 | -$795.14K 10-Q · filed 2021-10-27 | -$818.53K derived: sum of 4 quarters · filed 2022-04-14 | |||||
| 2020-06-30 | -$221.48K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-09-17 | -$315.34K 10-Q · filed 2021-09-17 | -$338.73K derived: sum of 3 quarters · filed 2022-04-14 | -$400.90K derived: sum of 4 quarters · filed 2022-04-14 | |||||
| 2020-03-31 | -$93.86K 10-Q · filed 2021-09-03 | -$117.25K derived: sum of 2 quarters · filed 2022-04-14 | -$179.42K derived: sum of 3 quarters · filed 2022-04-14 | -$190.68K derived: sum of 4 quarters · filed 2022-04-14 | |||||
| 2019-12-31 | -$23.39K derived: 10-K/A 12 month − 10-Q 9 month · filed 2022-04-14 | -$85.56K derived: sum of 2 quarters · filed 2022-04-14 | -$96.82K derived: sum of 3 quarters · filed 2022-04-14 | -$137.16K 10-K/A · filed 2022-04-14 | |||||
| 2019-09-30 | -$62.17K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-27 | -$73.43K derived: sum of 2 quarters · filed 2021-10-27 | -$113.77K 10-Q · filed 2021-10-27 | ||||||
| 2019-06-30 | -$11.25K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-09-17 | -$51.60K 10-Q · filed 2021-09-17 | |||||||
| 2019-03-31 | -$40.34K 10-Q · filed 2021-09-03 | ||||||||
| 2018-12-31 | -$451.50K 10-K · filed 2021-04-23 | ||||||||
| 2017-12-31 | -$1.06M 10-K · filed 2021-04-23 | ||||||||
| 2014-12-31 | $4.79M derived: 10-K 12 month − 10-Q 9 month · filed 2015-05-22 | $4.09M derived: sum of 2 quarters · filed 2015-05-22 | $2.82M derived: sum of 3 quarters · filed 2015-05-22 | $2.50M 10-K · filed 2015-05-22 | |||||
| 2014-09-30 | -$697.58K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-19 | -$1.97M derived: sum of 2 quarters · filed 2014-11-19 | -$2.29M 10-Q · filed 2014-11-19 | $9.17M derived: sum of 4 quarters · filed 2015-05-22 | |||||
| 2014-06-30 | -$1.27M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-12 | -$1.59M 10-Q · filed 2014-08-12 | $9.87M derived: sum of 3 quarters · filed 2015-05-22 | $8.35M derived: sum of 4 quarters · filed 2015-05-22 | |||||
| 2014-03-31 | -$316.50K 10-Q · filed 2014-05-15 | $11.14M derived: sum of 2 quarters · filed 2015-05-22 | $9.62M derived: sum of 3 quarters · filed 2015-05-22 | $7.76M derived: sum of 4 quarters · filed 2015-05-22 | -$100.64M 10-Q · filed 2014-05-15 | ||||
| 2013-12-31 | $11.46M derived: 10-K 12 month − 10-Q 9 month · filed 2015-05-22 | $9.94M derived: sum of 2 quarters · filed 2015-05-22 | $8.07M derived: sum of 3 quarters · filed 2015-05-22 | $6.00M 10-K · filed 2015-05-22 | -$6.03M 10-K · filed 2014-04-15 | -$100.32M 10-K · filed 2014-04-15 | |||
| 2013-09-30 | -$1.52M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-19 | -$3.38M derived: sum of 2 quarters · filed 2014-11-19 | -$5.46M 10-Q · filed 2014-11-19 | -$7.60M derived: sum of 4 quarters · filed 2014-11-19 | |||||
| 2013-06-30 | -$1.87M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-12 | -$3.94M 10-Q · filed 2014-08-12 | -$6.09M derived: sum of 3 quarters · filed 2014-08-12 | -$8.17M derived: sum of 4 quarters · filed 2014-08-12 | |||||
| 2013-03-31 | -$2.07M 10-Q · filed 2014-05-15 | -$4.22M derived: sum of 2 quarters · filed 2014-05-15 | -$6.31M derived: sum of 3 quarters · filed 2014-05-15 | -$9.04M derived: sum of 4 quarters · filed 2014-05-15 | |||||
| 2012-12-31 | -$2.14M derived: 10-K 12 month − 10-Q 9 month · filed 2014-04-15 | -$4.23M derived: sum of 2 quarters · filed 2014-04-15 | -$6.97M derived: sum of 3 quarters · filed 2014-04-15 | -$9.21M 10-K · filed 2014-04-15 | |||||
| 2012-09-30 | -$2.09M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-19 | -$4.83M derived: sum of 2 quarters · filed 2013-11-19 | -$7.07M 10-Q · filed 2013-11-19 | -$9.14M derived: sum of 4 quarters · filed 2013-11-19 | |||||
| 2012-06-30 | -$2.74M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-14 | -$4.98M 10-Q · filed 2013-08-14 | -$7.05M derived: sum of 3 quarters · filed 2013-08-14 | -$9.09M derived: sum of 4 quarters · filed 2013-08-14 | |||||
| 2012-03-31 | -$2.24M 10-Q · filed 2013-05-15 | -$4.31M derived: sum of 2 quarters · filed 2013-05-15 | -$6.36M derived: sum of 3 quarters · filed 2013-05-15 | -$8.11M derived: sum of 4 quarters · filed 2013-05-15 | |||||
| 2011-12-31 | -$2.07M derived: 10-K 12 month − 10-Q 9 month · filed 2013-04-05 | -$4.11M derived: sum of 2 quarters · filed 2013-04-05 | -$5.87M derived: sum of 3 quarters · filed 2013-04-05 | -$7.67M 10-K · filed 2013-04-05 | |||||
| 2011-09-30 | -$2.05M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-14 | -$3.80M derived: sum of 2 quarters · filed 2012-11-14 | -$5.61M 10-Q · filed 2012-11-14 | -$7.04M derived: sum of 4 quarters · filed 2012-11-14 | -$83.01M 10-Q · filed 2011-11-14 | ||||
| 2011-06-30 | -$1.75M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-14 | -$3.56M 10-Q · filed 2012-08-14 | -$5.00M derived: sum of 3 quarters · filed 2012-08-14 | -$7.17M derived: sum of 4 quarters · filed 2012-08-14 | -$80.97M 10-Q · filed 2011-08-15 | ||||
| 2011-03-31 | -$1.81M 10-Q · filed 2012-05-15 | -$3.24M derived: sum of 2 quarters · filed 2012-05-15 | -$5.42M derived: sum of 3 quarters · filed 2012-05-15 | ||||||
| 2010-12-31 | -$1.44M derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-30 | -$3.61M derived: sum of 2 quarters · filed 2012-03-30 | -$7.41M 10-K · filed 2012-03-30 | ||||||
| 2010-09-30 | -$2.18M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-14 | -$5.98M 10-Q · filed 2011-11-14 | |||||||
| 2010-06-30 | -$3.80M 10-Q · filed 2011-08-15 |